400 related articles for article (PubMed ID: 33930428)
21. KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis.
Du L; Kim JJ; Shen J; Chen B; Dai N
Oncotarget; 2017 Mar; 8(13):22175-22186. PubMed ID: 28077799
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of single-cell transcriptome reveals heterogeneity and commonality in the immune microenvironment of colorectal cancer and inflammatory bowel disease.
Lv H; Mu Y; Zhang C; Zhao M; Jiang P; Xiao S; Sun H; Wu N; Sun D; Jin Y
Front Immunol; 2024; 15():1356075. PubMed ID: 38529274
[TBL] [Abstract][Full Text] [Related]
23. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability.
Koinuma K; Yamashita Y; Liu W; Hatanaka H; Kurashina K; Wada T; Takada S; Kaneda R; Choi YL; Fujiwara SI; Miyakura Y; Nagai H; Mano H
Oncogene; 2006 Jan; 25(1):139-46. PubMed ID: 16247484
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic and genetic analysis of WNT signaling pathway in sporadic colorectal cancer patients from Iran.
Naghibalhossaini F; Zamani M; Mokarram P; Khalili I; Rasti M; Mostafavi-Pour Z
Mol Biol Rep; 2012 May; 39(5):6171-8. PubMed ID: 22207181
[TBL] [Abstract][Full Text] [Related]
26. New Methylation Biomarker Panel for Early Diagnosis of Dysplasia or Cancer in High-Risk Inflammatory Bowel Disease Patients.
Azuara D; Aussó S; Rodriguez-Moranta F; Guardiola J; Sanjuan X; Lobaton T; Boadas J; Piqueras M; Monfort D; Guinó E; Moreno V; Capellá G; de Oca J
Inflamm Bowel Dis; 2018 Nov; 24(12):2555-2564. PubMed ID: 30099509
[TBL] [Abstract][Full Text] [Related]
27. Somatic mutation profiles as molecular classifiers of ulcerative colitis-associated colorectal cancer.
Mäki-Nevala S; Ukwattage S; Olkinuora A; Almusa H; Ahtiainen M; Ristimäki A; Seppälä T; Lepistö A; Mecklin JP; Peltomäki P
Int J Cancer; 2021 Jun; 148(12):2997-3007. PubMed ID: 33521965
[TBL] [Abstract][Full Text] [Related]
28. Molecular phenotype of inflammatory bowel disease-associated neoplasms with microsatellite instability.
Schulmann K; Mori Y; Croog V; Yin J; Olaru A; Sterian A; Sato F; Wang S; Xu Y; Deacu E; Berki AT; Hamilton JP; Kan T; Abraham JM; Schmiegel W; Harpaz N; Meltzer SJ
Gastroenterology; 2005 Jul; 129(1):74-85. PubMed ID: 16012936
[TBL] [Abstract][Full Text] [Related]
29. MGMT-B gene promoter hypermethylation in patients with inflammatory bowel disease - a novel finding.
Mokarram P; Kavousipour S; Sarabi MM; Mehrabani G; Fahmidehkar MA; Shamsdin SA; Alipour A; Naini MA
Asian Pac J Cancer Prev; 2015; 16(5):1945-52. PubMed ID: 25773792
[TBL] [Abstract][Full Text] [Related]
30. Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning.
Mori Y; Olaru AV; Cheng Y; Agarwal R; Yang J; Luvsanjav D; Yu W; Selaru FM; Hutfless S; Lazarev M; Kwon JH; Brant SR; Marohn MR; Hutcheon DF; Duncan MD; Goel A; Meltzer SJ
Endocr Relat Cancer; 2011 Aug; 18(4):465-78. PubMed ID: 21636702
[TBL] [Abstract][Full Text] [Related]
31. Discrimination of low- and high-grade appendiceal mucinous neoplasms by targeted sequencing of cancer-related variants.
LaFramboise WA; Pai RK; Petrosko P; Belsky MA; Dhir A; Howard PG; Becich MJ; Holtzman MP; Ahrendt SA; Pingpank JF; Zeh HJ; Dhir R; Bartlett DL; Choudry HA
Mod Pathol; 2019 Jul; 32(8):1197-1209. PubMed ID: 30962504
[TBL] [Abstract][Full Text] [Related]
32. Single Nucleotide Polymorphisms in Colitis-Associated Colorectal Cancer: A Current Overview with Emphasis on the Role of the Associated Genes Products.
Makaro A; Fichna J; Włodarczyk M
Curr Drug Targets; 2020; 21(14):1456-1462. PubMed ID: 32718287
[TBL] [Abstract][Full Text] [Related]
33. Transcriptome analysis of potential candidate genes and molecular pathways in colitis-associated colorectal cancer of Mkp-1-deficient mice.
Hammad A; Zheng ZH; Namani A; Elshaer M; Wang XJ; Tang X
BMC Cancer; 2021 May; 21(1):607. PubMed ID: 34034704
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical analysis of HNF4A and β-catenin expression to predict low-grade dysplasia in the colitis-neoplastic sequence.
He Y; Chen L; Chen K; Sun Y
Acta Biochim Biophys Sin (Shanghai); 2021 Jan; 53(1):94-101. PubMed ID: 33300557
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
[TBL] [Abstract][Full Text] [Related]
36. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH; Bae JM; Cho NY; Kang GH
Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
[TBL] [Abstract][Full Text] [Related]
37. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
[TBL] [Abstract][Full Text] [Related]
38. Two subtypes of colorectal tumor with distinct molecular features in familial adenomatous polyposis.
Takane K; Matsusaka K; Ota S; Fukuyo M; Yue Y; Nishimura M; Sakai E; Matsushita K; Miyauchi H; Aburatani H; Nakatani Y; Takayama T; Matsubara H; Akagi K; Kaneda A
Oncotarget; 2016 Dec; 7(51):84003-84016. PubMed ID: 27563825
[TBL] [Abstract][Full Text] [Related]
39. Whole blood ACTB, B2M and GAPDH expression reflects activity of inflammatory bowel disease, advancement of colorectal cancer, and correlates with circulating inflammatory and angiogenic factors: Relevance for real-time quantitative PCR.
Bednarz-Misa I; Neubauer K; Zacharska E; Kapturkiewicz B; Krzystek-Korpacka M
Adv Clin Exp Med; 2020 May; 29(5):547-556. PubMed ID: 32424999
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia.
Isidro RA; Cruz ML; Isidro AA; Baez A; Arroyo A; González-Marqués WA; González-Keelan C; Torres EA; Appleyard CB
World J Gastroenterol; 2015 Feb; 21(6):1749-58. PubMed ID: 25684939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
